Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
07/2002
07/11/2002WO2002008221A3 Capsaicin receptor ligands
07/11/2002WO2001040187A3 Compound having effect of promoting neuron differentiation
07/11/2002WO2001003685A3 Novel prodrugs for antimicrobial amidines
07/11/2002US20020091274 Taxane derivatives having an amino substituted C13 side chain useful as antileukemia and antitumor agents
07/11/2002US20020091260 Selective control of harmful plants in crops of useful plants
07/11/2002US20020091152 Medicament for treatment of irritable bowel syndrome
07/10/2002EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity
07/10/2002EP0738148B1 Self-assembled taxo-diperpenoid nanostructures
07/09/2002US6417192 Pyrimidinone compounds and pharmaceutical compositions containing them
07/09/2002US6417162 Female impotence treated with heterocyclic compound containing nitro groups
07/09/2002CA2244519C C-4":substituted macrolide antibiotics
07/04/2002WO2002051820A1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
07/04/2002WO2002036556A3 Acylaminoalkyl-substituted benzenesulfonamide derivatives
07/03/2002EP1218360A1 Triazine kinase inhibitors
07/03/2002EP0681573B1 C2 Taxane derivatives and pharmaceutical compositions containing them
07/03/2002CN1356987A Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds
07/02/2002US6413956 Substituted 4-oxo-quinoline-3-carboxamides
07/02/2002US6413947 Antiinflammatory agents; rheumatic diseases; anticholesterol agents
07/02/2002US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity
06/2002
06/27/2002WO2002050082A2 Inhibitors of papilloma virus
06/27/2002WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors
06/27/2002WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors
06/27/2002WO2002050031A1 Indole derivatives
06/27/2002WO2002022602A3 Triazole compounds useful as protein kinase inhibitors
06/26/2002EP0877614B1 Method for inducing death of neoplastic cells using piperazine oxirane derivatives
06/26/2002EP0830137A4 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
06/25/2002US6410756 Family of Canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof
06/25/2002US6410590 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them
06/25/2002US6410571 Viricides
06/25/2002US6410566 Cyclic amine derivatives and their use as drugs
06/20/2002WO2002048134A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
06/20/2002US20020077341 C10 carbamoyloxy substituted taxanes
06/20/2002CA2430992A1 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
06/19/2002CN1354798A Process for preparation of pseudomonic acid A antibiotic by microbiological method
06/19/2002CN1354740A Pharmaceutical compounds
06/18/2002US6407249 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
06/18/2002US6407123 Diaminopyridine-containing thiourea inhibitors of herpes viruses
06/13/2002WO2002046177A1 A process for the preparation of paclitaxel
06/13/2002WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002WO2002046150A2 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2002US20020072485 Administering prior to the impairment of glucose and/or oxygen to the brain an NMDA receptor subunit (NR2B) selective NMDA antagonist to inhibit neuronal damage (ischemia)
06/13/2002CA2431045A1 Compounds which mimic the chemical and biological properties of discodermolide
06/13/2002CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/12/2002EP0888327B1 Benzopyran derivatives having leukotriene-antagonistic action
06/12/2002EP0688212B1 C9 taxane derivatives and pharmaceutical compositions containing them
06/12/2002CN1353703A tricyclic fused heterocycle compounds, process for preparing the same and use thereof
06/11/2002US6403617 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, humanherpesviruses-6 and -7, and kaposi herpesvirus
06/06/2002US20020068755 Antitumor agents.
06/06/2002US20020068332 Generating expression vector coding polyketide synthases; generate nucleotide sequences, obtain cells, transform cells, recover polytketide synthases
06/05/2002EP1211250A1 C10 taxane derivatives and pharmaceutical compositions
06/05/2002EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors
06/04/2002US6399771 Cyclic imines as pesticides
06/04/2002US6399657 Antiinflammatory agents
06/04/2002US6399653 Ring fused dihydropyrans, process for preparation and use thereof
06/04/2002US6399382 Synthase catalyst biosynthesis
05/2002
05/30/2002WO2002043449A1 Luminescent element material and luminescent element comprising the same
05/30/2002WO2002042277A1 Novel compounds for use as hiv protease inhibitors
05/30/2002US20020065305 As antitumor agent
05/30/2002US20020065304 As antitumor agent
05/30/2002CA2428459A1 Novel compounds for use as hiv protease inhibitors
05/28/2002US6395895 Butenyl substituted β-lactams
05/28/2002US6395367 Electroconductivity
05/23/2002WO2002040475A1 Bombesin receptor antagonists
05/23/2002WO2002040462A2 Cysteine protease inhibitors
05/23/2002WO2001042179A9 Compounds which mimic the chemical and biological properties of discodermolide
05/23/2002US20020061874 Substituted lactam; gamma-secretase inhibitor; decreases production of beta-amyloid; treatment for Altzheimer's and Down's syndrome
05/23/2002CA2429329A1 Bombesin receptor antagonists
05/23/2002CA2428863A1 Cysteine protease inhibitors
05/22/2002EP1206462A2 Heterocyclic compounds inhibiting angiogenesis
05/22/2002EP1182200A9 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
05/22/2002EP0729463B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/22/2002EP0681575B1 Process for the preparation of Baccatin III analogs bearing new C2 and C4 functional groups
05/21/2002US6391913 Derivatives of paclitaxel, method for producing same and uses thereof
05/21/2002US6391594 Generating nucleotide sequence encoding genetically engineered polyketide synthase; obtain nucleotide sequences, insert into expression vectors, transform cells, recover enzymatic polypeptide
05/16/2002WO2002038553A2 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/16/2002WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors
05/16/2002US20020058821 C2 substituted taxanes
05/16/2002CA2421154A1 Peroxisome proliferator activated receptor alpha agonists
05/15/2002EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof
05/15/2002CN1349525A Di-aryl acid derivatives as PPAR receptor ligands
05/10/2002WO2002036556A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives
05/10/2002WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/09/2002US20020055094 Method of detection of influenza virus and compounds for use therein
05/08/2002EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases
05/08/2002EP0790994B1 Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/08/2002DE10054481A1 Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them
05/08/2002CN1348447A 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/08/2002CN1347869A Synthesis of ester ether compound with high acidolysis activity
05/02/2002WO2001096283A3 Hiv integrase inhibitors
05/02/2002US20020052403 Taxane formulations
05/02/2002EP1201650A2 Ionic malonitril derivatives and their uses
05/02/2002EP1200424A1 C7 heterosubstituted acetate taxanes as antitumor agents
05/02/2002EP0561883B1 Polymorphs of crystalline mupirocin
04/2002
04/30/2002US6380394 Anticancer agents
04/30/2002US6380246 For combating pests and weeds
04/30/2002US6380196 Bronchial therapeutics, bronchial dilators
04/30/2002CA2088931C Phosphonooxy and carbonate derivatives of taxol
04/25/2002WO2001092563A3 Method for detecting a detectable product
04/25/2002US20020049229 Agents for treating neuropathic pain
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 120